ArticleScandinavian journal of immunology2026
Similar Individual Serum Levels of MCP-1, TNF-α, and IL-6 From Periodontitis Patients Before and 1 Year After Treatment.
Article in Scandinavian journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Similar Individual Serum Levels of MCP-1, TNF-α, and IL-6 From Periodontitis Patients Before and 1 Year After Treatment.Scandinavian journal of immunology · 2026Article
- Periodontium-derived fibroblasts as a model to evaluate inflammation and pharmacological modulation of osteogenesis and osteoclast formation.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Treatment of periodontitis may lower the inflammation status as measured in sera from patients. To investigate this in a biological assay, we co-cultured periodontal ligament fibroblasts (PDLFs) from a healthy donor and peripheral blood mononuclear cells (PBMCs) as a source for osteoclasts. PDLFs were primed for 3 days with serum from periodontitis patients before and from 1 year after successful treatment of periodontitis (n = 13). After priming, PBMCs were added. No significant differences in the number of osteoclasts that formed after 3 weeks were found between baseline and after-treatment serum priming. To find an explanation, we analysed the serum composition on the presence of inflammatory, pro-osteoclastogenic cytokines. We found no differences between before and after treatment for cytokines MCP-1, TNF-α, and IL-6. Interestingly, these levels of cytokines at baseline and after treatment strongly correlated per individual (correlation p-value between p = 0.03 and p < 0.0001, correlation r
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.